Par Health is voluntarily recalling two lots of Brevital Sodium 500 mg/vial due to particulate matter (cellulose)…

US · 2026-10-09

1. Step 1 · The triggerPar Health recalls two lots of Brevital Sodium due to cellulose particulate contamination, halting distribution of an anesthesia induction agent
2. Step 2 · Knock-onhospital formularies and ambulatory surgery centers face immediate need to substitute methohexital sodium with alternative barbiturate or non-barbiturate anesthetic agents
3. Step 3 · Knock-ondemand surges for Baxter and Fresenius Kabi alternative products, tightening allocation and extending lead times for procurement
4. Step 4 · Knock-ondistributors and group purchasing organizations absorb expedited freight and vendor-qualification costs to maintain supply continuity
5. Step 5 · Reaches youthe SME distributor or ASC procurement operator faces higher input costs, tighter working capital requirements, and potential customer attrition if substitution fails

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: fda.gov

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.